Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,736
Total Claims
$1.2M
Drug Cost
1,045
Beneficiaries
$1,176
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-93%
Opioid rate vs peers
0.2% vs 2.6% avg
+10%
Cost per patient vs peers
$1,176 vs $1,068 avg
+71%
Brand preference vs peers
15.4% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
16
Opioid Claims
$165
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,334 claims · $1.1M
Generic: 7,331 claims · $158K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 184 | $236K |
| Apixaban | 140 | $137K |
| Empagliflozin | 73 | $86K |
| Dapagliflozin Propanediol | 81 | $79K |
| Linagliptin | 47 | $47K |
| Sitagliptin Phosphate | 30 | $43K |
| Rivaroxaban | 33 | $43K |
| Semaglutide | 34 | $39K |
| Insulin Glargine,hum.Rec.Anlog | 57 | $31K |
| Tiotropium Bromide | 17 | $26K |
| Fluticasone/Umeclidin/Vilanter | 37 | $25K |
| Budesonide/Formoterol Fumarate | 34 | $20K |
| Sacubitril/Valsartan | 21 | $19K |
| Linaclotide | 12 | $17K |
| Tirzepatide | 13 | $16K |
Prescribing Profile
Patient Profile
65
Avg Age
64%
Female
1.85
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data